Unknown

Dataset Information

The associations of cerebrospinal fluid biomarkers with cognition, and rapid eye movement sleep behavior disorder in early Parkinson's disease.


ABSTRACT:

Background

In Parkinson's disease (PD), levels of cerebrospinal fluid (CSF) biomarkers and progression of non-motor symptoms are associated, but the specifics are not yet clear.

Objective

The aim of this study was to investigate the associations of non-motor symptoms with CSF biomarkers in PD.

Materials and methods

We assessed 487 individuals from the Parkinson's Progression Markers Initiative (PPMI), consisting of 155 healthy controls (HCs) and 332 individuals with PD. Patients with PD were grouped according to non-motor symptoms and compared CSF α-synuclein (α-syn), amyloid-beta 1-42 (Aβ1-42), and total tau (t-tau) levels. Multiple linear regressions were used in baseline analysis and linear mixed-effects models in longitudinal analysis. Analyses of media

SUBMITTER: Tao M 

PROVIDER: S-EPMC9728099 | biostudies-literature | 2022

REPOSITORIES: biostudies-literature